drugset / Trial / NCT00247624

Improving Sleep and Psychological Functioning in People With Depression and Insomnia

NCT00247624 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

This study will evaluate the safety and effectiveness of treatment with both a sleeping pill and antidepressant medication in improving sleep and psychological functioning in people with depression and insomnia.

Timeline

Start
2005-10
Primary completion
2008-10
Completion
2008-12

Outcome

Met primary endpoint

paper patients receiving ESZ had lower (better) DLRF scores (0.81 +/- 0.64) than those receiving placebo (1.2 +/- 0.72), p = 0.01. PMID 20726279 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Eszopiclone Small molecule 3 mg —
Background Fluoxetine Small molecule 20 mg —